Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2002
05/21/2002US6391642 Transformation-associated recombination cloning
05/21/2002US6391641 Translationally-coupled reporter gene
05/21/2002US6391640 Methods and compositions for cellular and metabolic engineering
05/21/2002US6391639 Regulatory sequence for use generating transgenic plants; for use in expression of heterologus genes in plants
05/21/2002US6391637 Activating genetically engineered cells to generate preferential immunoglobulins; obtain cells, incubate with preferential polypeptides, recover preferential immunoglobulins
05/21/2002US6391636 Nucleotide sequences for use in treating cell proliferation defects
05/21/2002US6391634 Monoclonal antibodies and their production and use
05/21/2002US6391633 Genetically engineered cells for use as tools in the expression of heterologous genes
05/21/2002US6391632 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
05/21/2002US6391631 Nucleotide sequences for use as tools in genetic engineering and analysis
05/21/2002US6391630 Nucleotide sequences for use in the diagnosis, prevention and treatment of cancer
05/21/2002US6391613 Motor proteins and methods for their use
05/21/2002US6391612 Replicating preferential plasmids; obtain nuclelotide sequences, transform cells, allow replication, recover plasmids
05/21/2002US6391607 Human DNase I hyperactive variants
05/21/2002US6391606 Peptides; for use in the develoment of human diagnostic and therapeutic agents
05/21/2002US6391605 Modified phytases
05/21/2002US6391604 Thermostable enzyme having phosphatidylethanolamine N-methyltransferase activity
05/21/2002US6391603 Genes of purine biosynthesis from Ashbya gossypii and the use thereof in microbial riboflavin synthesis
05/21/2002US6391601 Transport protein for use in the treatment of cell proliferation defects, cancer, hyperplasias, restenosis, cardiovascular, immune and inflammatory disorders
05/21/2002US6391600 PcrA helicase
05/21/2002US6391595 Transferase and amylase, process for producing the enzymes, use thereof, and gene coding for the same
05/21/2002US6391594 Generating nucleotide sequence encoding genetically engineered polyketide synthase; obtain nucleotide sequences, insert into expression vectors, transform cells, recover enzymatic polypeptide
05/21/2002US6391593 Detecting preferential nucleotide sequences; obtain samples, incubate with probes, amplify nucleotide sequences, detect amplified nucleotide sequences
05/21/2002US6391589 Human chemokine beta-10 mutant polypeptides
05/21/2002US6391588 Nucleotides squences coding preferential amino acid sequences for use in treating bone disorder in mammals
05/21/2002US6391586 Nucleotide sequences which codes heterologous polypeptide for use generation of human therapeutics
05/21/2002US6391585 Plasmid for use as tool in generation of genetic engineering heterologous proteins
05/21/2002US6391584 Expression-cloning method for identifying target proteins for eukaryotic tyrosine kinases and novel target proteins
05/21/2002US6391583 Generating lovastatin; obtain cells, transform, recover lovastatin
05/21/2002US6391582 Shuttle vectors
05/21/2002US6391581 DNA encoding interleukin-4 receptors
05/21/2002US6391580 Ras proteins
05/21/2002US6391579 Nucleotide sequences coding transport protein for use in the treatment of thyroid defects
05/21/2002US6391574 AFC1 and RCE1: isoprenylated CAAX processing enzymes
05/21/2002US6391573 Contacting protein having microtubule stimulated atpase (adenosine triphosphatase) activity with compound at several different concentrations and measuring activity of protein; difference in activity indicates modulator
05/21/2002US6391569 Method to detect Dirofilaria immitis infection
05/21/2002US6391566 Drug screening of ligands which interact with receptor of defined amino acid sequence incubating by incubating ligand with recombinant cell or membrane which expresses receptor
05/21/2002US6391563 Method for the determination of antigens with the aid of three or more monoclonal antibodies
05/21/2002US6391562 Array of a plurality of particles having probes, respectively, fixed thereon, said probes being capable of binding to different target substances to be examined, respectively
05/21/2002US6391560 Contacting rna attatched to a solid support with arrays of oligonucleotides to form duplexes, then contacting with rnase (ribonuclease), and measuring kinetics of cleavage; for screening libraries
05/21/2002US6391554 Detecting cancerous conditions by assaying for telomerase activity
05/21/2002US6391553 Analyzing level of gene expression of epsilon 4 or epsilon 2 alleles of apolipoprotein e; mutation in consensus sequence binding a transcription factor and either increase in epsilon 4 or decrease in epsilon 2 indicate disease
05/21/2002US6391552 Enhancing transfection efficiency of vectors by recursive recombination
05/21/2002US6391551 Simple, automatable method of determining presence of endogenous target sequence in sample by mixing target sequence hybridized with 3'-labeled probe with enzyme that releases nucleotides from 3'-end, and analyzing for label
05/21/2002US6391548 Simple and efficent method of introducing specific mutations by using two primers, synthesizing dna using linear cyclic amplification where dna may form into a double-strand, then digesting dna using selection enzyme
05/21/2002US6391547 Microbial β-glucuronidase genes, gene products and uses thereof
05/21/2002US6391546 Performing two assymetric polymeraase chain reactions using different primers, heating and cooling amplification products to obtain partially double-stranded nucleotide sequence, then detecting sequence
05/21/2002US6391545 Multiple antibiotic resistance operon assays
05/21/2002US6391543 Screening sample for preferential nucleotide sequences; incubate sample with nucleotide sequences, monitor sample for signal indicating bound nucleotide sequences
05/21/2002US6391542 Oligonucleotides of defined nucleotide sequence; antisense agents; viricides; diagnostic probes
05/21/2002US6391316 Vaccine compositions comprising Haemophilus somnus transferrin-binding proteins and methods of use
05/21/2002US6391302 Method for treating cancers which present antigen FB5 with humanized antibodies
05/21/2002US6391299 Anti-factor IX/IXa antibodies
05/21/2002US6391296 Method of stabilizing useful protein and useful protein compositions
05/21/2002US6391285 Antimicrobial polypeptide and methods of use
05/21/2002US6390821 Phosphorylation
05/21/2002CA2363518A1 Methods and computer software products for predicting nucleic acid hybridization affinity
05/21/2002CA2246073C Clamping mechanism for keyboard support
05/21/2002CA2243759C Fluorescence detection assay for homogeneous pcr hybridization systems
05/21/2002CA2215745C Human stat4
05/21/2002CA2215310C Substrates for beta-lactamase and uses thereof
05/21/2002CA2183241C Yeast strains and modified albumins
05/21/2002CA2153254C Cloning of enterokinase and method of use
05/21/2002CA2139847C Probe for diagnosing infectious disease
05/21/2002CA2037664C Monoclonal antibody against complexed and noncomplexed complexing agents for removing heavy metals from aqueous solutions and for analysis
05/21/2002CA1341361C Human erythropoietin gene: high level expression in stably transfected mammalian cells
05/16/2002WO2002039123A1 Kit and method for detecting the esm-1 protein
05/16/2002WO2002039120A1 A method for identifying the proteome of cells using an antibody library microarray
05/16/2002WO2002039116A2 Retrovirus isolated from humans
05/16/2002WO2002038811A2 Assay for the detection and quantitation of hemimethylation
05/16/2002WO2002038810A2 Compositions and methods relating to prostate specific genes and proteins
05/16/2002WO2002038807A1 Method for screening agents capable of treating obesity
05/16/2002WO2002038805A2 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases
05/16/2002WO2002038792A2 Novel method for analysing phenotypic characteristics of human immunodeficiency virus (hiv)
05/16/2002WO2002038788A2 Process for the fermentative preparation of l-amino acids using coryneform bacteria
05/16/2002WO2002038787A2 Secondary liquefaction of starch in ethanol production
05/16/2002WO2002038785A2 Process for the preparation of trans-carveol
05/16/2002WO2002038783A1 Vector
05/16/2002WO2002038782A2 Viral expression system
05/16/2002WO2002038780A2 Use of a nucleic acid to provide a plant with resistance to attack by a pathogen
05/16/2002WO2002038779A1 A transformation system in camelina sativa
05/16/2002WO2002038778A1 Differentiation-inducing substances
05/16/2002WO2002038777A2 Enzymes and encoding genes from methylophilus methylotrophus
05/16/2002WO2002038776A1 Regulation of human fatty acid coa ligase
05/16/2002WO2002038775A2 METHODS FOR PRODUCING AND PURIFYING RECOMBINANT α-L-IDURONIDASE
05/16/2002WO2002038774A2 Bacterial phytases and method for producing same
05/16/2002WO2002038773A2 A human phospholipase c and uses thereof
05/16/2002WO2002038772A1 Nucleotide sequences which code for the nadc gene
05/16/2002WO2002038770A1 Yeast derived vaccine against ipnv
05/16/2002WO2002038769A2 Dna sequences, which code for optimised eukaryotic hpv 16-l1 and hpv 16-l2
05/16/2002WO2002038768A1 Manipulation of plant life cycles and/or growth phases
05/16/2002WO2002038767A2 G protein-coupled receptor protein and nucleic acid molecules and uses therefor
05/16/2002WO2002038766A2 Human tumor necrosis factor receptor
05/16/2002WO2002038765A2 Dna encoding bovine immunoglobulin a inducing protein and uses therefor
05/16/2002WO2002038764A2 Il-17 receptor-like protein, uses thereof, and modulation of catabolic activity of il-17 cytokines on bone and cartilage
05/16/2002WO2002038763A1 Pca2501 gene
05/16/2002WO2002038762A1 Method of acquiring gene specific to nerve formation of vertebrate
05/16/2002WO2002038761A2 Regulation of human oat-like protein
05/16/2002WO2002038760A2 Regulation of human extracellular calcium-sensing g protein-coupled receptor
05/16/2002WO2002038759A2 Method for inducing apoptiosis